Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
INOSIM is a German software company that develops process simulation and digital twin software for process industries, including pharmaceuticals and life sciences, but it is not itself a drug-development or healthcare company. Its core offerings include INOSIM Insight for process simulation and digital twin modeling and INOSIM Foresight for simulation-based real-time decision support in plant operations. The software is used to model, analyze, and optimize batch, hybrid, and continuous production environments across the plant lifecycle, from design and engineering through operation and production planning. INOSIM also provides related consulting, training, and simulation project services. The company is active and operating, and ZETA has announced the acquisition of a majority stake in INOSIM Software GmbH, integrating the business into ZETA's pharma and biotech-focused digital solutions portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on INOSIM Software.